Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01492036 · ClinicalTrials.gov registry record
Long-Term Follow-Up of Recipient of Gene Transfer Research
A clinical trial of Cancer and Retroviridae Infections, sponsored by M.D. Anderson Cancer Center.
- Recruiting
- Registry status
- 130
- Enrollment target
- 1
- Study location
NCT01492036: Recruiting study of Cancer and Retroviridae Infections, sponsored by M.D. Anderson Cancer Center.
NCT01492036 is a study of Cancer and Retroviridae Infections that is actively recruiting participants, run by M.D. Anderson Cancer Center. The registered enrollment target is 130 participants, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01492036, a study of Cancer and Retroviridae Infections, is actively recruiting participants, sponsored by M.D. Anderson Cancer Center.
- RECRUITING
- Registry status
- 130 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical research study is to collect information about the long-term safety of gene transfer therapy. This study is also designed to create a database of medical information about patients who have received gene transfer therapy, in order for researchers to track and review the long-term safety and any effects (good or bad) of gene transfer therapy.
Primary Outcome
First 5 years following infusion of vector or vector-treated cells: Participants evaluated on annual basis. Years 6 to 15 following infusion of vector or vector-treated cells: Participants mailed questionnaires. Participants in retroviral studies: Up to 60 mL (max 1 mL/kg) blood will be obtained to check for replication-competent retrovirus (RCR) every 3 months during the first year, and then blood archived annually thereafter. Replication competent vector testing performed when there is a clini
Conditions Studied
Interventions
- OTHER Blood Tests
- BEHAVIORAL Questionnaires
Study Locations (1)
Texas
- University of Texas MD Anderson Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 130 participants |
| Start Date | 2011-12-09 |
| Est. Completion | 2027-12-31 |
What NCT01492036 shows while recruiting
NCT01492036 is an observational study that tracks outcomes without assigning an intervention. The registered 130 participants enrollment target is mid-sized for trials with a published cap, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (96% lower).
The record links to 2 conditions, with Cancer appearing as the primary indexed condition, and to 2 interventions - of which Blood Tests is the first listed.
NCT01492036 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT01492036 about?
NCT01492036 is a clinical study titled "Long-Term Follow-Up of Recipient of Gene Transfer Research". The goal of this clinical research study is to collect information about the long-term safety of gene transfer therapy. This study is also designed to create a database of medical information about patients who have received gene transfer therapy, in order for researchers to track and review the lon...
What is the current status of trial NCT01492036?
This trial is currently recruiting. The enrollment target is 130 participants. The study started on 2011-12-09. Estimated completion is 2027-12-31.
What conditions does trial NCT01492036 study?
This clinical trial studies the following conditions: Cancer, Retroviridae Infections.
What interventions are being tested in trial NCT01492036?
The interventions under investigation include: Blood Tests (OTHER), Questionnaires (BEHAVIORAL).
Who is sponsoring clinical trial NCT01492036?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01492036 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01492036's enrollment target sits among peer trials
130 277th of 615 higher than 336 of 615 other Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Registry Study to Evaluate the Clinical Outcome of Cancer Patients and Benign Diseases Treated with Radiation
RECRUITING
-
Treatment of Immune Checkpoint Inhibitor-related Diarrhea and/ or Colitis With Ustekinumab in Cancer Patients
RECRUITING · Phase 2
-
IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)
RECRUITING · NA
-
A Natural History Study of Metabolic Sizing in Health and Disease
RECRUITING
-
Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer
RECRUITING · Phase 1
-
BfedBwell Optimization Pilot
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01631617 · 130 participants · Phase 2
Effects of Treatments on Atopic Dermatitis
- NCT02368041 · 130 participants
Utility of Thenar Near Infrared Spectroscopy (NIRS) in Pediatric Patients With Heart Failure
- NCT02604277 · 130 participants · NA
Suicidal Behavior in Patients Diagnosed With Bipolar Disorder
- NCT02708836 · 130 participants · NA
Limiting Emergence Phenomena After General Anesthesia With Combined LMA and ETT Airway Management Technique
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI